Geode Capital Management’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $254K | Buy |
|
|||||
|
2023
Q2 | $94.5K | Sell |
|
|||||
|
2023
Q1 | $110K | Buy |
|
|||||
|
2022
Q4 | $977K | Buy |
|
|||||
|
2022
Q3 | $1.23M | Buy |
|
|||||
|
2022
Q2 | $731K | Sell |
|
|||||
|
2022
Q1 | $1.85M | Buy |
|
|||||
|
2021
Q4 | $3.18M | Buy |
|
|||||
|
2021
Q3 | $3.67M | Buy |
|
|||||
|
2021
Q2 | $6.49M | Buy |
|
|||||
|
2021
Q1 | $4.13M | Buy |
|
|||||
|
2020
Q4 | $3.95M | Buy |
|
|||||
|
2020
Q3 | $1.09M | Buy |
|
|||||
|
2020
Q2 | $779K | Buy |
|
|||||
|
2020
Q1 | $531K | Buy |
|
|||||
|
2019
Q4 | $514K | Buy |
|
|||||
|
2019
Q3 | $726K | Buy |
|
|||||
|
2019
Q2 | $1.07M | Buy |
|
|||||
|
2019
Q1 | $819K | Buy |
|
|||||
|
2018
Q4 | $1.17M | Buy |
|
|||||
|
2018
Q3 | $628K | Buy |
|
|||||
|
2018
Q2 | $587K | Buy |
|